Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03040102 · ClinicalTrials.gov registry record · NA

Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers

A NA study of Advanced Cancer, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
194
Enrollment target
1
Study location

NCT03040102 is a NA study of Advanced Cancer that has completed, run by Massachusetts General Hospital. The registered enrollment target is 194 participants, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03040102, a NA study of Advanced Cancer, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
194 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services

Conditions Studied

Interventions

  • OTHER Standard of Care
  • OTHER Hospice Video Educational Tool

Study Locations (1)

Massachusetts

  • Massachusetts general Hospital - Boston

Trial Details

FieldValue
Enrollment Target 194 participants
Start Date 2017-03-09
Est. Completion 2019-02-01
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03040102

The ClinicalTrials.gov registry entry for NCT03040102 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 194 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 245-participant average among 122 other Advanced Cancer trials with a reported enrollment target (21% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Advanced Cancer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT03040102 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03040102 about?

NCT03040102 is a clinical study titled "Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers". The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services

What is the current status of trial NCT03040102?

This trial is currently completed. It is a NA study. The enrollment target is 194 participants. The study started on 2017-03-09. Estimated completion is 2019-02-01.

What conditions does trial NCT03040102 study?

This clinical trial studies the following conditions: Advanced Cancer.

What interventions are being tested in trial NCT03040102?

The interventions under investigation include: Standard of Care (OTHER), Hospice Video Educational Tool (OTHER).

Who is sponsoring clinical trial NCT03040102?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03040102 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.